Atlas Trials

Pharmtechnology LLC

27 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pharmtechnology LLC

RecordFirmDate
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions (NCT06213610)Pharmtechnology LLC2024-01-09
Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions (NCT05940909)Pharmtechnology LLC2023-06-24
Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions (NCT05685277)Pharmtechnology LLC2022-12-28
Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions (NCT05642845)Pharmtechnology LLC2022-11-19
Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions (NCT05438316)Pharmtechnology LLC2022-06-17
Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions (NCT05339373)Pharmtechnology LLC2022-04-15
Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions (NCT04921566)Pharmtechnology LLC2021-06-05
Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions (NCT04882826)Pharmtechnology LLC2021-05-10
Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions (NCT04830579)Pharmtechnology LLC2021-04-10
Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions (NCT04729998)Pharmtechnology LLC2021-01-30
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions (NCT04138888)Pharmtechnology LLC2019-10-31
Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions (NCT04038008)Pharmtechnology LLC2019-07-26
The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions (NCT04012307)Pharmtechnology LLC2019-07-11
The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions. (NCT03951051)Pharmtechnology LLC2019-05-06
Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions (NCT03918551)Pharmtechnology LLC2019-05-03
A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions (NCT03898011)Pharmtechnology LLC2019-03-23
Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions (NCT03915340)Pharmtechnology LLC2019-03-23
Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions (NCT03898193)Pharmtechnology LLC2019-03-23
Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions (NCT03799536)Pharmtechnology LLC2019-01-09
Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions (NCT03702894)Pharmtechnology LLC2018-09-21
Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State (NCT03705533)Pharmtechnology LLC2018-09-07
Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions (NCT03616301)Pharmtechnology LLC2018-07-28
Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg/5ml and Nurofen®, Oral Suspension 100 mg/5 ml in Healthy Volunteers Under Fasting Conditions (NCT03561558)Pharmtechnology LLC2018-06-11
A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions (NCT03459911)Pharmtechnology LLC2018-02-16

Track Pharmtechnology LLC automatically

Every clearance here is in the API, with alerts when new ones post.